11.95  3.69 (44.67%)		10-31 00:00
Open: 7.955 High: 21.42 Volume: 1,176,367		Pre. Close: 8.26 Low: 7.81 Market Cap: 235(M)

Short term
Mid term
Targets	6-month :	18.37	1-year :	25.01
Resists	First :	15.72	Second :	21.42
Pivot price	11.94
Supports	First :	6.51	Second :	5.42
MAs	MA(5) :	11.94	MA(20) :	11.07
	MA(100) :	10.35	MA(250) :	10.16
MACD	MACD :	0.5	Signal :	0.4
%K %D	K(14,3) :	34.4	D(3) :	35.7
RSI	RSI(14): 72.3
52-week	High :	21.42	Low :	6.51

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ BHSE ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	21.44 - 21.54	21.54 - 21.63
Low:	7.72 - 7.76	7.76 - 7.8
Close:	11.85 - 11.95	11.95 - 12.04

Bull Horn Holdings Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the sports, entertainment, and brand sectors. The company was incorporated in 2018 and is based in Miami Beach, Florida.

Tue, 01 Nov 2022
Coeptis Therapeutics closes SPAC deal with Bull Horn - The Pharma Letter

Mon, 31 Oct 2022
Coeptis Therapeutics, Inc. Announces Closing of Business Combination with Bull Horn Holdings Corp. - PR Newswire

Wed, 21 Sep 2022
Coeptis Therapeutics Enters Exclusive License Agreement with University of Pittsburgh for Rights to SNAP-CAR, a ... - PR Newswire

Wed, 20 Apr 2022
Cancer-Focused Coeptis Therapeutics Turns To SPAC Deal To Uplist To NASDAQ - Yahoo Finance

Tue, 19 Apr 2022
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement - PR Newswire

Fri, 03 Dec 2021
Toronto Blue Jays, Denver Broncos And More Sports Teams Could Be For Sale: Will A SPAC Land A Deal? - Rog - Benzinga

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	9 (M)
Shares Float	6 (M)
Held by Insiders	20 (%)
Held by Institutions	73.7 (%)
Shares Short	2 (K)
Shares Short P.Month	3 (K)

EPS	-0.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.59
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-0.8 %
Return on Equity (ttm)	611.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-77.5 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-199.17
PEG Ratio	0
Price to Book value	-20.26
Price to Sales	0
Price to Cash Flow	-186.73

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.